Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondria quality control in disease.

Market:

Capacity Bio's lead focus is neurodegeneration and muscular disorders, including Parkinson’s, ALS, and DMD which targets multibillion opportunities.

Technology:

Capacity Bio has a unique set of drugs that improve mitochondrial quality control by targeting receptors on the cell surface.

Advantages:

  • Engage target quickly and efficiently
  • No need to enter the cell or mitochondria
  • Safe and effective

Development Stage:

  • Pre-clinical

Patents Issued:

  • Coming soon

Select Publications:

Contact:

Website: capacitybio.com
Email: info@capacitybio.com

Back to Top